BioRestorative Therapies Growth Metrics (2010-2025)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Growth Metrics	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)	-8.05M	-2.13M	-4.20M	-7.52M	5.21M	1.72M	3.02M	-4.64M	1.31M	0.17M	0.58M	10.99M	0.67M	0.21M	0.91M	1.05M	-0.75M	0.17M	-3.05M	-1.33M
EBITDA Margin Growth (3y) (Quarter)	-7.19M	-1.82M	-4.15M	-7.27M	-2.36M	0.04M	-1.11M	-11.98M	-1.53M	-0.24M	-0.60M	-1.17M	7.19M	2.09M	4.51M	7.40M	1.24M	0.54M	-1.55M	10.70M
EBITDA Margin Growth (5y) (Quarter)	-6.10M	-1.04M	-1.18M	-4.94M	0.40M	0.63M	-0.50M	-12.24M	-0.67M	0.07M	-0.55M	-0.92M	-0.37M	0.41M	0.38M	0.05M	-1.61M	0.13M	-2.74M	-1.45M
EBITDA Margin (QoQ) (Quarter)	-7.86M	5.99M	-2.24M	-3.41M	4.86M	2.51M	-0.94M	-11.06M	10.81M	1.36M	-0.53M	-0.66M	0.49M	0.90M	0.18M	-0.52M	-1.30M	1.81M	-3.03M	1.19M
EBIT Margin Growth (1y) (Quarter)	-8.05M	-2.13M	-4.20M	-7.52M	5.21M	1.72M	3.02M	-4.64M	1.31M	0.17M	0.58M	10.99M	0.67M	0.21M	0.91M	1.05M	-0.75M	0.17M	-3.05M	-1.33M
EBIT Margin Growth (3y) (Quarter)	-7.19M	-1.82M	-4.15M	-7.27M	-2.36M	0.04M	-1.11M	-11.98M	-1.53M	-0.24M	-0.60M	-1.17M	7.19M	2.09M	4.51M	7.40M	1.24M	0.54M	-1.55M	10.70M
EBIT Margin Growth (5y) (Quarter)	-6.10M	-1.04M	-1.18M	-4.94M	0.40M	0.63M	-0.50M	-12.24M	-0.67M	0.07M	-0.55M	-0.92M	-0.37M	0.41M	0.38M	0.05M	-1.61M	0.13M	-2.74M	-1.45M
EBIT Margin (QoQ) (Quarter)	-7.86M	5.99M	-2.24M	-3.41M	4.86M	2.51M	-0.94M	-11.06M	10.81M	1.36M	-0.53M	-0.66M	0.49M	0.90M	0.18M	-0.52M	-1.30M	1.81M	-3.03M	1.19M
EBT Margin Growth (1y) (Quarter)	-7.93M	-2.43M	-4.82M	-7.45M	5.20M	2.10M	3.62M	-4.67M	1.32M	0.17M	0.59M	11.07M	0.65M	0.21M	0.92M	1.06M	-0.94M	0.16M	-3.05M	-12.84M
EBT Margin Growth (3y) (Quarter)	-7.16M	-2.20M	-4.77M	-7.29M	-2.34M	0.03M	-1.16M	-11.99M	-1.41M	-0.16M	-0.61M	-1.04M	7.17M	2.48M	5.13M	7.47M	1.03M	0.54M	-1.54M	-0.71M
EBT Margin Growth (5y) (Quarter)	-6.07M	-1.43M	-1.77M	-5.02M	0.39M	0.63M	-0.45M	-12.35M	-0.64M	0.07M	-0.56M	-0.89M	-0.36M	0.41M	0.35M	0.15M	-1.70M	0.21M	-2.73M	-12.82M
EBT Margin (QoQ) (Quarter)	-7.73M	5.63M	-2.47M	-2.87M	4.91M	2.52M	-0.95M	-11.16M	10.90M	1.37M	-0.53M	-0.67M	0.48M	0.93M	0.18M	-0.53M	-1.52M	2.03M	-3.02M	-10.33M
Enterprise Value Growth (1y) (Quarter)	-52,220.27%	-490.10%	-541.91%	-586.11%	-672.62%		-1,359.37%	29.85%	35.96%		-18.91%	24.97%	-146.66%	25.34%	33.24%	3.01%	70.14%	49.72%	65.69%	72.49%
Enterprise Value Growth (3y) (Quarter)	-563.45%	-692.89%	-120.50%	-463.49%	-238.93%		-451.83%	-1,969.54%	-1,273.08%	-304.05%	-381.15%	-53.42%	-130.24%	-102.84%	-126.27%	20.08%	22.16%		35.18%	41.50%
Enterprise Value Growth (5y) (Quarter)	-47.92%	-27.79%	-182.17%	-266.45%	-365.32%		-641.80%	-100.81%	-328.52%	-461.31%	-184.39%	-148.18%	-127.92%	-62.80%	-166.09%	-477.98%	-352.95%	-90.00%	-91.14%	0.74%
Enterprise Value (QoQ) (Quarter)	18.39%	29.66%	35.78%	-1,761.24%	8.10%			10.54%	16.10%	-58.91%	0.30%	43.55%	-175.82%	51.90%	10.85%	18.00%	15.09%	19.01%	39.17%	34.23%
FCF Margin Growth (1y) (Quarter)	-0.28M	-0.27M	-0.44M	-1.95M	-0.61M	0.30M	0.29M	-2.19M	0.30M	-0.01M	0.10M	3.62M	0.10M	-0.00M	0.31M	0.31M	-0.46M	0.12M	-2.38M	-0.72M
FCF Margin Growth (3y) (Quarter)	0.16M	-0.21M	-0.27M	-1.75M	-0.38M	0.26M	-0.04M	-3.92M	-0.60M	0.01M	-0.04M	-0.52M	-0.22M	0.28M	0.71M	1.74M	-0.06M	0.11M	-1.97M	3.22M
FCF Margin Growth (5y) (Quarter)	1.53M	0.17M	1.69M	-0.53M	0.68M	0.19M	-0.17M	-4.12M	-0.16M	0.07M	0.13M	-0.32M	0.01M	0.25M	0.38M	0.02M	-0.95M	0.13M	-2.11M	-0.93M
FCF Margin (QoQ) (Quarter)	-0.12M	-0.04M	-0.29M	-1.50M	1.22M	0.87M	-0.30M	-3.99M	3.71M	0.56M	-0.18M	-0.47M	0.19M	0.46M	0.13M	-0.47M	-0.58M	1.04M	-2.37M	1.19M
Gross Margin Growth (1y) (Quarter)														-728.00	-781.00	-771.00	-0.00M	441.00	-0.01M	-64.00
Gross Margin Growth (3y) (Quarter)
Gross Margin Growth (5y) (Quarter)
Gross Margin (QoQ) (Quarter)											0.00M	0.00M	0.00M	-728.00	-53.00	10.00	-392.00	876.00	-0.01M	0.01M
Interest Coverage Ratio Growth (1y) (Quarter)	-16,708.62%	-121.83%	91.74%	-2,904.20%	67.41%	-1,172.16%	-1,160.84%	-13.37%	-11.02%	-74.68%	-102.40%	33.21%	76.99%	-517.99%	-1,314.76%	18.90%	73.18%	98.93%		99.73%
Interest Coverage Ratio Growth (3y) (Quarter)	-153.97%	73.51%	80.14%	-93.43%	-88.66%	32.71%	-96.68%	-159.85%	-293.25%	-266.67%	-28.20%	-183.34%	56.33%	-415.93%	-612.06%	15.00%	59.08%	51.33%		88.62%
Interest Coverage Ratio Growth (5y) (Quarter)	-51.11%	57.29%	41.79%		11.35%		-43.59%	13.75%	-42.75%	16.21%	27.54%	-40.52%	-11.40%	-26.89%	-176.83%	-56.88%	-30.29%	-26.61%		45.02%
Interest Coverage Ratio (QoQ) (Quarter)	-11,180.66%	98.40%	-22.15%	-1,260.37%	-22.37%	37.44%	-21.06%	-22.32%	-19.84%	1.57%	-40.27%	59.64%	58.71%	-2,543.38%	-221.12%	97.69%	86.34%	-5.23%
Net Margin Growth (1y) (Quarter)	-7.93M	-2.43M	-4.82M	-7.45M	5.20M	2.10M	3.62M	-4.67M	1.32M	0.17M	0.59M	11.07M	0.65M	0.21M	0.92M	1.06M	-0.94M	0.16M	-3.05M	-12.84M
Net Margin Growth (3y) (Quarter)	-7.16M	-2.20M	-4.77M	-7.29M	-2.34M	0.03M	-1.16M	-11.99M	-1.41M	-0.16M	-0.61M	-1.04M	7.17M	2.48M	5.13M	7.47M	1.03M	0.54M	-1.54M	-0.71M
Net Margin Growth (5y) (Quarter)	-6.07M	-1.43M	-1.77M	-5.02M	0.39M	0.63M	-0.45M	-12.35M	-0.64M	0.07M	-0.56M	-0.89M	-0.36M	0.41M	0.35M	0.15M	-1.70M	0.21M	-2.73M	-12.82M
Net Margin (QoQ) (Quarter)	-7.73M	5.63M	-2.47M	-2.87M	4.91M	2.52M	-0.95M	-11.16M	10.90M	1.37M	-0.53M	-0.67M	0.48M	0.93M	0.18M	-0.53M	-1.52M	2.03M	-3.02M	-10.33M
Operating Margin Growth (1y) (Quarter)	-8.05M	-2.13M	-4.20M	-7.52M	5.21M	1.72M	3.02M	-4.64M	1.31M	0.17M	0.58M	10.99M	0.67M	0.21M	0.91M	1.05M	-0.75M	0.17M	-3.05M	-1.33M
Operating Margin Growth (3y) (Quarter)	-7.19M	-1.82M	-4.15M	-7.27M	-2.36M	0.04M	-1.11M	-11.98M	-1.53M	-0.24M	-0.60M	-1.17M	7.19M	2.09M	4.51M	7.40M	1.24M	0.54M	-1.55M	10.70M
Operating Margin Growth (5y) (Quarter)	-6.10M	-1.04M	-1.18M	-4.94M	0.40M	0.63M	-0.50M	-12.24M	-0.67M	0.07M	-0.55M	-0.92M	-0.37M	0.41M	0.38M	0.05M	-1.61M	0.13M	-2.74M	-1.45M
Operating Margin (QoQ) (Quarter)	-7.86M	5.99M	-2.24M	-3.41M	4.86M	2.51M	-0.94M	-11.06M	10.81M	1.36M	-0.53M	-0.66M	0.49M	0.90M	0.18M	-0.52M	-1.30M	1.81M	-3.03M	1.19M
Return on Assets Growth (1y) (Quarter)	1.00	-2.00	-6.00	-1.00	4.00	5.00	9.00	1.00	0.00M	0.00M	0.00M	0.00M	0.00M	1.00	0.00M	0.00M	0.00M	-1.00	-1.00	-7.00
Return on Assets Growth (3y) (Quarter)	1.00	0.00M	-4.00	4.00	5.00	3.00	3.00	5.00	4.00	3.00	2.00	0.00M	3.00	6.00	9.00	1.00	0.00M	-1.00	-1.00	-7.00
Return on Assets Growth (5y) (Quarter)	0.00M	-2.00			5.00	5.00	5.00	4.00	4.00	5.00	5.00	5.00	5.00	3.00	4.00	5.00	4.00	3.00	1.00	-7.00
Return on Assets (QoQ) (Quarter)	-3.00	-2.00	-3.00	7.00	1.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	-1.00	-6.00
Return on Capital Employed Growth (1y) (Quarter)	-0.07M	-0.02M	0.14M	-0.01M	0.04M	0.09M	0.12M	0.01M	-0.00M	-0.05M	0.00M	0.00M	0.01M	0.05M	0.00M	0.00M	-0.01M	-0.01M	-0.03M	-0.13M
Return on Capital Employed Growth (3y) (Quarter)	-0.07M	-0.11M	-0.15M	-0.03M	-0.03M	-0.02M	-0.02M	-0.02M	-0.03M	0.03M	0.26M	534.00	0.05M	0.09M	0.13M	0.01M	0.01M	-0.01M	-0.02M	-0.12M
Return on Capital Employed Growth (5y) (Quarter)	-0.08M	-0.13M			-0.04M	-0.03M	-0.03M	-0.03M	-0.04M	-0.07M	-0.02M	-0.02M	-0.02M	-0.02M	-0.02M	-0.02M	-0.02M	0.06M	0.24M	-0.12M
Return on Capital Employed (QoQ) (Quarter)	-0.05M	-0.04M	-0.04M	0.12M	-0.00M	0.01M	-0.00M	88.00	-0.01M	-0.03M	0.04M	0.00M	0.00M	437.00	-213.00	-712.00	-0.01M	-0.01M	-0.02M	-0.10M
Return on Sales Growth (1y) (Quarter)	-793.00	-243.00	-482.00	-745.00	520.00	210.00	362.00	-467.00	132.00	17.00	59.00	0.00M	65.00	21.00	92.00	106.00	-94.00	16.00	-305.00	-0.00M
Return on Sales Growth (3y) (Quarter)	-716.00	-220.00	-477.00	-729.00	-234.00	3.00	-116.00	-0.00M	-141.00	-16.00	-61.00	-104.00	717.00	248.00	513.00	747.00	103.00	54.00	-154.00	-71.00
Return on Sales Growth (5y) (Quarter)	-607.00	-143.00	-177.00	-502.00	39.00	63.00	-45.00	-0.00M	-64.00	7.00	-56.00	-89.00	-36.00	41.00	35.00	15.00	-170.00	21.00	-273.00	-0.00M
Return on Sales (QoQ) (Quarter)	-773.00	563.00	-247.00	-287.00	491.00	252.00	-95.00	-0.00M	0.00M	137.00	-53.00	-67.00	48.00	93.00	18.00	-53.00	-152.00	203.00	-302.00	-0.00M

Research Tools

Datasets

Plans

Developers

BioRestorative Therapies BRTX Growth Metrics (2010-2025)

Research Tools

Datasets

Plans

Developers

BioRestorative Therapies BRTX Growth Metrics (2010-2025)

Create an account

Sign In

Reset Password